Japanese / English

Nippon Shinyaku’s R&D Activities

Therapeutic Areas Hematology

Nippon Shinyaku has focused on hematology since 1971. As an area of focus in both market and R&D, we are expanding our pipeline in this field not only by in-house drug discovery but also by in-licensing.

Key drugs for hematological malignancies